The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Diabetes Prevention Program (DPP) and its Outcomes Study (DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization. We report the 10-year within-trial cost-effectiveness of the interventions. RESEARCH DESIGN AND METHODS: Data on resource utilization, cost, and quality of life were collected prospectively. Economic analyses were performed from health system and societal perspectives. RESULTS: Over 10 years, the cumulative, undiscounted per capita direct medical costs of the interventions, as implemented during the DPP, were greater for lifestyle ($4,572) than metformin ($2,281) or placebo ($752). The cumulative direct medical costs of care outside the DPP/DPPOS were least for lifestyle ($26,810 lifestyle vs. $27,384 metformin vs. $29,007 placebo). The cumulative, combined total direct medical costs were greatest for lifestyle and least for metformin ($31,382 lifestyle vs. $29,665 metformin vs. $29,759 placebo). The cumulative quality-adjusted life-years (QALYs) accrued over 10 years were greater for lifestyle (6.89) than metformin (6.79) or placebo (6.74). When costs and outcomes were discounted at 3% and adjusted for survival, lifestyle cost $12,878 per QALY, and metformin had slightly lower costs and nearly the same QALYs as placebo. CONCLUSIONS: Over 10 years, from a payer perspective, lifestyle was cost-effective and metformin was marginally cost-saving compared with placebo. Investment in lifestyle and metformin interventions for diabetes prevention in high-risk adults provides good value for the money spent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to potential for type 2 diabetes risk reduction, metformin therapy is also a feasible strategy in real world settings, given its association with cost savings. 15”
From Metformin Prescription Rates for Patients with Prediabetes (2022) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both DPP-modeled intensive lifestyle interventions and individualized MNT for prediabetes have demonstrated costeffectiveness (17,36)”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Does Preventive Care Save Money? Health Economics and the Presidential Candidates
Cohen, J. T., Neumann, P. J., & Weinstein, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708558 · Cited by 471 · cited 1×
“Unfortunately, fewer than 1 in 5 new interventions in health and medicine are cost-saving compared with usual care (17).”
BackgroundThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Self-citationRenjilian, D. A., Perri, M. G., Nezu, A. M., McKelvey, W. F., Shermer, R. L., & Anton, S. D. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.69.4.717 · Cited by 327 · cited 2×
“Studies have shown that group intervention programs can be as effective as individual programs (12,13).”
BackgroundClinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
Eddy, D. M., Schlessinger, L., & Kahn, R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00006 · Cited by 318 · cited 2×
“However, one analysis suggested that lifestyle might be too expensive for health plans or a national program to implement (10).”
Background
Research works printed but not linked: 1
- Gold MR Siegel JE Russell LB Weinstein MC (Eds.). Cost-effectiveness in health and medicine. New York, Oxford University Press, 1996
Cited by
Items 201–300 of 499
Su, C.-L., Wang, L., Ho, C., Nfor, O. N., Hsu, S., Lee, C., Ko, P., Lin, Y.-T., & Liaw, Y. (2020) · Medicine · doi:10.1097/md.0000000000019613 · Cited by 21
Goldfine, A. B., Phua, E.-J., & Abrahamson, M. J. (2014) · Circulation · doi:10.1161/circulationaha.113.006634 · Cited by 16
High-Intensity Exercise Training for the Prevention of Type 2 Diabetes Mellitus
Rynders, C. A., & WELTMAN, A. L. (2014) · The Physician and Sportsmedicine · doi:10.3810/psm.2014.02.2042 · Cited by 20
Metformin prescribing in low-income and insured patients with prediabetes
Wu, J., Ward, E. D., Threatt, T. B., & Lu, K. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.04.008 · Cited by 16
Srivastava, P., Verma, A., Geronimo, C., & Button, T. M. (2019) · SAGE Open Medicine · doi:10.1177/2050312119841986 · Cited by 18
Olson, D. E., Ming, Z., Long, Q., Barb, D., HAW, J. S., Rhee, M. K., Mohan, A. V., Watson-Williams, P. I., Jackson, S. L., Tomolo, A. M., et al. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3075-7 · Cited by 17
Brunisholz, K. D., Joy, E. A., Hashibe, M., Gren, L. H., Savitz, L. A., Hamilton, S., Cannon, W., & Kim, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157729 · Cited by 17
Metformin Prescription Rates for Patients with Prediabetes
Hughes, A., Khan, T., Kirley, K., Moin, T., Mainous, A., Sachdev, N., Williams, J., & Wozniak, G. (2022) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2022.04.210485 · Cited by 15
“15 Thus, our goal was to focus on metformin prescription rates for the 3 groups identi-fi ed as most likely to bene fi t.”
BackgroundTherapeutic Challenges in Diabetes Prevention: We Have Not Found the “Exercise Pill”
Srinivasan, S., & Florez, J. C. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.146 · Cited by 16
Arakawa, S., Watanabe, T., Sone, H., Tamura, Y., Kobayashi, M., Kawamori, R., Atsumi, Y., Oshida, Y., Tanaka, S., Suzuki, S., et al. (2014) · Diabetology International · doi:10.1007/s13340-014-0166-y · Cited by 20
Garner, N. J., Pascale, M., France, K., Ferns, C., Clark, A., Auckland, S., & Sampson, M. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000619 · Cited by 16
Booth, J. E., Benham, J. L., Schinbein, L. E., McGinley, S. K., Rabi, D. M., & Sigal, R. J. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.03.012 · Cited by 15
Ferreira, J. P., Lamiral, Z., Xhaard, C., Duarte, K., Bresso, E., Devignes, M., Floch, É. L., Dandine‐Roulland, C., Deleuze, J., Wagner, S., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0246 · Cited by 16
Ackermann, R. T., Holmes, A. M., & Saha, C. (2013) · Preventing Chronic Disease · doi:10.5888/pcd10.120149 · Cited by 16
Wu, J., Ward, E. D., Threatt, T. B., & Lu, K. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.3.309 · Cited by 19
Trends in Medical Expenditures Prior to Diabetes Diagnosis: The Early Burden of Diabetes
Khan, T., Yang, J., & Wozniak, G. (2020) · Population Health Management · doi:10.1089/pop.2019.0143 · Cited by 15
Delahanty, L. M., Chang, Y., Levy, D. E., Porneala, B., Dushkin, A., Bissett, L., Goldman, V., Perrotta, J., Rodriguez, A. R., Chase, B., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.05.018 · Cited by 15
Huelgas, R. G., Peralta, F. G., Fernández, L. C., Galve, E., Casanueva, F. F., Puig‐Domingo, M., Bravo, J. J. M., Orozco‐Beltrán, D., Muñoz, J. E., Torre, E. L. M., et al. (2015) · Revista Clínica Española · doi:10.1016/j.rce.2015.07.003 · Cited by 21
Alzubaidi, H., Hasan, S., Saidawi, W., Namara, K. M., Chandir, S., & Krass, I. (2021) · Diabetic Medicine · doi:10.1111/dme.14598 · Cited by 14
Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics
Ng, T. W., Khan, A. A., & Meikle, P. J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.75 · Cited by 14
McCoy, R. G., Nori, V. S., Smith, S. A., & Hane, C. A. (2016) · Health Services Research · doi:10.1111/1475-6773.12461 · Cited by 14
Steps Toward the Meaningful Translation of Prevention Strategies for Type 2 Diabetes
Cefalu, W. T. (2012) · Diabetes Care · doi:10.2337/dc12-0119 · Cited by 14
Radl, K., Ianuale, C., & Boccia, S. (2022) · Epidemiology, Biostatistics, and Public Health · doi:10.2427/8846 · Cited by 13
Unick, J. L., Pellegrini, C. A., DUNSIGER, S. I., Demos, K. E., Thomas, J. G., Bond, D. S., Lee, R. H., Webster, J., & Wing, R. R. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.14587 · Cited by 14
Bruce, K., Garrido, A. N., Zhang, S., & Lam, T. K. T. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2025 · Cited by 14
Point-Counterpoint Debate: Surgery vs Medical Treatment for the Management of Obesity
Schauer, P. R., & Rothberg, A. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae888 · Cited by 16
Effects of multiple cycles of weight loss and regain on the body weight regulatory system in rats
Rosenbaum, J. L., Frayo, R. S., Melhorn, S. J., Cummings, D. E., & Schur, E. A. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2019 · Cited by 14
Lifestyle intervention for obesity: a call to transform the clinical care delivery system in Mexico
Díaz-Zavala, R. G., Candia-Plata, M. D. C., Martínez-Contreras, T. D. J., & Esparza‐Romero, J. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s208884 · Cited by 15
Metformin use in prediabetes: is earlier intervention better?
Warrilow, A., Somerset, S. M., Pumpa, K. L., & Fleet, R. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01559-9 · Cited by 15
Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study
Hu, W., Xu, W., Si, L., Wang, C., Jiang, Q., Wang, L., & Cutler, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242962 · Cited by 14
Meenan, R. T., Stumbo, S. P., Yarborough, M. T., Leo, M. C., Yarborough, B. J. H., & Green, C. A. (2015) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-015-0669-2 · Cited by 15
Baillot, A., Pelletier, C., Dunbar, P., Geiss, L. S., Johnson, J. A., Leiter, L. A., & Langlois, M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.022 · Cited by 17
Pharmacologic Randomized Clinical Trials in Prevention of Type 2 Diabetes
Knowler, W. C., & Crandall, J. P. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1268-5 · Cited by 14
Laxy, M., Zhang, P., Ng, B. P., Shao, H., Ali, M. K., Albright, A. L., & Gregg, E. W. (2020) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00565-w · Cited by 14
Protocol for the Mason: Health Starts Here prospective cohort study of young adult college students
Cuellar, A. E., Adams, L. M., de Jonge, L., Espina, V. A., Espinoza, L., Fischer, S. F., Frankenfeld, C. L., Hines, D. A., Kornienko, O., Lawrence, H. Y., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10969-5 · Cited by 14
The Imperative to Prevent Diabetes
Ratner, R. E. (2012) · Diabetes Care · doi:10.2337/dc12-1997 · Cited by 14
Carris, N. W., Tipparaju, S. M., Magness, D. J., Chapalamadugu, K. C., & Magness, R. R. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.07.007 · Cited by 12
A Prospective Programmatic Cost Analysis of Fuel Your Life: A Worksite Translation of DPP
Ingels, J. B., Walcott, R. L., Wilson, M. G., Corso, P. S., Padilla, H. M., Zuercher, H., DeJoy, D. M., & Vandenberg, R. J. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000868 · Cited by 12
Shao, H., Lin, J., Zhuo, X., Rolka, D. B., Gregg, E. W., & Zhang, P. (2019) · Diabetes Care · doi:10.2337/dc19-0381 · Cited by 15
Feldman, D. I., Valero-Elizondo, J., Salami, J. A., Rana, J. S., Ogunmoroti, O., Osondu, C. U., Spatz, E. S., Virani, S. S., Blankstein, R., Blaha, M. J., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.004 · Cited by 11
Looking back: a review of policy implications for exercise oncology
Kennedy, M. A., Potiaumpai, M., Maitin‐Shepard, M., Wilson, C. M., Campbell, A., Schwartz, A. L., Gorzelitz, J., Caru, M., Grimmett, C., & Schmitz, K. H. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad002 · Cited by 11
Screening for diabetes and impaired glucose metabolism in Qatar: Models’ development and validation
Sadek, K., Abdelhafez, I., Al‐Hashimi, I., Al‐Shafi, W., Tarmizi, F., Al-Marri, H., Alzohari, N., Balideh, M., & Carr, A. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.10.002 · Cited by 12
Risk factors associated with glycated hemoglobin A1c trajectories progressing to type 2 diabetes
Halalau, A., Roy, S., Hegde, A., Khanal, S., Langnas, E., Raja, M., & Homayouni, R. (2023) · Annals of Medicine · doi:10.1080/07853890.2022.2164347 · Cited by 13
Fuzzy Expert System for Type 2 Diabetes Mellitus (T2DM) Management Using Dual Inference Mechanism
Nnamoko, N., Arshad, F., England, D., & Vora, J. P. (2013) · Edge Hill University Research Information Repository (Edge Hill University) · Cited by 11
Typ 2 Diabetes mellitus – Screening und Prävention: Update 2016
Stadler, M., Fröhlich-Reiterer, E. E., & Prager, R. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-0971-3 · Cited by 11
Prevention of type 2 diabetes: what is the right target population?
Williamson, D. A. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1535896 · Cited by 13
Herman, W. H., Joiner, K. L., Hurst, T. E., & McEwen, L. N. (2021) · Diabetes Care · doi:10.2337/dc20-3112 · Cited by 11
Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes
Cha, E., Paul, S., Braxter, B., Umpierrez, G. E., & Faulkner, M. S. (2018) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721718756057 · Cited by 12
Five-year effectiveness of short messaging service (SMS) for pre-diabetes
Wong, C. K. H., Siu, S., Wong, K.-W., Yu, E. Y. T., & Lam, C. L. K. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3810-y · Cited by 13
Vitamin D suppresses cellular pathways of diabetes complication in liver.
Derakhshanian, H., Djalali, M., Hassan, M. A., Alvandi, E., Eshraghian, M. R., Mirshafiey, A., Nadimi, H., Jahanabadi, S., Zarei, M., & Djazayery, A. (2019) · PubMed Central · doi:10.22038/ijbms.2019.36054.8584 · Cited by 11
“Modification of lifestyle and especially an appropriate diet is one of the primary solutions in this regard (5).”
BackgroundPreventing type 2 diabetes: scaling up to create a prevention system
Johnson, G., Martin, J. E., & Timoshanko, A. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.01153 · Cited by 14
Weinhold, I., Schindler, C. J. A., Kossack, N., Berndt, B., & Häckl, D. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01086-7 · Cited by 13
Theoretical advances in mobile health communication research
Brew‐Sam, N., & Chib, A. I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816958-2.00008-3 · Cited by 10
Johnson, S. T., Lier, D. A., Soprovich, A., Mundt, C., & Johnson, J. A. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.08.001 · Cited by 10
Noninvasive skin fluorescence spectroscopy for detection of abnormal glucose tolerance
Hull, E. L., Matter, N. I., Olson, B. P., Ediger, M. N., Magee, A. J., Way, J. F., Vugrin, K. E. W., & Maynard, J. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.06.003 · Cited by 14
Vascular repair strategies in type 2 diabetes: novel insights.
Kuschnerus, K., Landmesser, U., & Kränkel, N. (2015) · PubMed Central · doi:10.3978/j.issn.2223-3652.2015.05.11 · Cited by 10
Lifestyle Approaches and Glucose Intolerance
Stull, A. J. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614554186 · Cited by 12
Böhme, P., Luc, A., Gillet, P., & Thilly, N. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0472-3 · Cited by 10
Lifetime cost for type 2 diabetes mellitus in Singapore
Ang, G. Y., Yap, C. W., & You, A. X. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12604 · Cited by 10
Khalifah, R. A. A., Thabane, L., Tarnopolsky, M. A., & Morrison, K. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12675 · Cited by 12
Cost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program
Hollenbeak, C. S., Weinstock, R. S., Cibula, D. A., Delahanty, L. M., & Trief, P. M. (2016) · Health Services Insights · doi:10.4137/hsi.s39084 · Cited by 12
Park, S., Ballreich, J. M., Ward, T., & Shi, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15807 · Cited by 10
“…DPP was based on year 1 intervention costs of the lifestyle intervention arm reported in a multicentre clinical trial of the in-person DPP. 44 The formal healthcare sector costs were derived by first estimating the cost ratio for each category within the total formal healthcare sector…”
InfluentialTeoh, K. W., Baek, Y., Ademi, Z., & Lee, S. W. H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16350 · Cited by 9
Chinese Guidelines for Medical Nutrition Therapy for Patients with Diabetes (2022 Edition).
(2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0001 · Cited by 15
The changing cost to prevent diabetes: A retrospective analysis of the Diabetes Prevention Program
Carris, N. W., Cheng, F., & Kelly, W. N. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.05.015 · Cited by 10
Redefining avoidable and inappropriate admissions
Coldron, B. C., MacRury, S. M., COATES, V. E., & Khamis, A. (2021) · Public Health · doi:10.1016/j.puhe.2021.11.004 · Cited by 9
Loomba, R. S. (2014) · Hepatology · doi:10.1002/hep.27314 · Cited by 9
Radically upgrading diabetes prevention in England
Maruthappu, M., Sood, H. S., & Keogh, B. E. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00079-0 · Cited by 10
Gebregergish, S. B., Hashim, M., Heeg, B. M. S., Wilke, T., Rauland, M., & Gottwald‐Hostalek, U. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1688146 · Cited by 9
Early arteriosclerosis and its risk factors in subjects with prediabetes and new-onset diabetes
Liu, X., Liu, L., Wang, R., Jia, X., Liu, B., Ma, N., & Lü, Q. (2021) · Endocrine Connections · doi:10.1530/ec-21-0202 · Cited by 9
Bouchi, R., Izumi, K., Ishizuka, N., Uemura, Y., Ohtsu, H., Miyo, K., Tanaka, S., Satoh‐Asahara, N., Hara, K., Odawara, M., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14227 · Cited by 10
Berry, T. R., Chan, C. B., Bell, R. C., & Walker, J. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00161 · Cited by 8
Primary Prevention of Type 2 Diabetes: An Imperative for Developing Countries
Dagogo-Jack, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-41559-8_2 · Cited by 8
Behavioral Economics: Tools for Promotion of Physical Activity
Leonard, T., & Shuval, K. (2017) · Routledge eBooks · doi:10.4324/9781315637938-5 · Cited by 9
Duru, O. K., Mangione, C. M., Turk, N., Chon, J. S., Fu, J., Cheng, G., Cheng, F., Moss, A., Frosch, D. L., Jeffers, K. S., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0829 · Cited by 8
Edshteyn, I., Uduhiri, K. A., Morgan, T. O., Rhodes, K., & Sherin, K. M. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.05.010 · Cited by 8
A call to action on prediabetes
Dugan, J. A., Cantillep, A., Newberry, K., & Shubrook, J. H. (2018) · JAAPA · doi:10.1097/01.jaa.0000545064.33107.8f · Cited by 8
An economic model for the use of yoghurt in type 2 diabetes risk reduction in the UK
Lenoir‐Wijnkoop, I., Mahon, J., Claxton, L., Wooding, A., Prentice, A. M., & Finer, N. (2016) · BMC Nutrition · doi:10.1186/s40795-016-0115-1 · Cited by 8
Unick, J. L., Pellegrini, C. A., DUNSIGER, S. I., Demos, K. E., Thomas, J. G., Bond, D. S., Webster, J., & Wing, R. R. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.105953 · Cited by 7
Grabner, M., Chen, Nguyen, Abbott, A., & Quimbo (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s46896 · Cited by 7
Baatiema, L., Strachan, D. L., Okoibhole, L. O., Kretchy, I. A., Kushitor, M. K., Awuah, R. B., Sanuade, O. A., Danyki, E. K., Amon, S., Adjaye-Gbewonyo, K., et al. (2024) · Global Health Action · doi:10.1080/16549716.2024.2364498 · Cited by 8
Screening for impaired fasting glucose and diabetes using available health plan data
McEwen, L. N., Adams, S. R., Schmittdiel, J. A., Ferrara, A. M., Selby, J. V., & Herman, W. H. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.01.003 · Cited by 7
Diabetes prevention in the real world: Insights from the JDPP and J‐ DOIT 1
Sakane, N. (2017) · Journal of General and Family Medicine · doi:10.1002/jgf2.85 · Cited by 9
Yeary, K. H. K., Kaplan, C. M., & Hutchins, E. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101084 · Cited by 7
Ejelonu, O. C., Elekofehinti, O. O., Adanlawo, I. G., & Kundu, R. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100203 · Cited by 7
Sy, B. K., Wassil, M., Hassan, A., & Chen, J. (2022) · Patterns · doi:10.1016/j.patter.2022.100510 · Cited by 8
A Systematic Approach to Treating Early Metabolic Disease and Prediabetes
Carris, N. W., Bunnell, B. E., Mhaskar, R. S., DuCoin, C. G., & Stern, M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01455-9 · Cited by 8
Evidence supports prediabetes treatment
Neumiller, J. J., Kalyani, R. R., Herman, W. H., Grant, R. W., Wysham, C., Inzucchi, S. E., Hirsch, I. B., Fonseca, V. A., Buse, J. B., & Barrett, E. J. (2019) · Science · doi:10.1126/science.aax3548 · Cited by 7
Considering metformin as a second-line treatment for children and adolescents with prediabetes
Hosey, C. M., Halpin, K. L., & Yan, Y. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0200 · Cited by 6
Fitzpatrick, S. L., Mayhew, M., Catlin, C., Firemark, A. J., Gruß, I., Nyongesa, D. B., O'Keeffe-Rosetti, M. C., Rawlings, A. M., Smith, D. H., Smith, N. X., et al. (2022) · The Permanente Journal · doi:10.7812/tpp/21.056 · Cited by 6
Lee, M. H., Applegate, C. C., Shaffer, A. L., Emamaddin, A., Erdman, J. W., & Nakamura, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267876 · Cited by 6
Screening native botanicals for bioactivity: An interdisciplinary approach
Boudreau, A., Cheng, D. M., Ruiz, C., Ribnicky, D., Allain, L., Brassieur, C. R., Turnipseed, D. P., Cefalu, W. T., & Floyd, Z. E. (2014) · Nutrition · doi:10.1016/j.nut.2014.02.028 · Cited by 6
Costs of diabetes medication among male former elite athletes in later life
Laine, M. K., Kujala, R., Eriksson, J. G., Kautiainen, H., Sarna, S. J., & Kujala, U. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0947-9 · Cited by 6
Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012
Rodríguez‐Gutiérrez, R., & Montori, V. M. (2015) · Annals of Internal Medicine · doi:10.7326/l15-5136 · Cited by 6
Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012
Moin, T., Duru, O. K., & Mangione, C. M. (2015) · Annals of Internal Medicine · doi:10.7326/l15-5136-2 · Cited by 6
Xiong, Y., Huo, Z., Wong, S. Y. S., & Yip, B. H. K. (2023) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.89 · Cited by 6
Financial incentives in the management of diabetes: a systematic review
Zhang, Q., Wei, X., Zheng, J., Lu, Y., & Wu, Y. (2024) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-024-00579-4 · Cited by 5
Dahal, P. K., Ademi, Z., Rawal, L. B., Mahumud, R. A., Paudel, G., Karmacharya, B. M., Sakamoto, H., Sugishita, T., & Vandelanotte, C. (2024) · Global Health Research and Policy · doi:10.1186/s41256-024-00364-z · Cited by 5
Alolayan, S. O., Eguale, T., Segal, A. R., Doucette, J. A., & Rittenhouse, B. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251315415 · Cited by 5
Insights Offered by Economic Analyses
Herman, W. H. (2014) · Diabetes Care · doi:10.2337/dc14-1232 · Cited by 5
Metadata
- Authors
- The Diabetes Prevention Program Research Group
- Affiliations
- University of Michigan (US)
- Corresponding author
- The Diabetes Prevention Program Research Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-03-13
- Volume
- 35
- Issue
- 4
- Pages
- 723-730
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3308273
- OpenAlex
- W1896651021
- Cited by
- 436
- References
- 22
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 22 · 2023: 19 · 2022: 19 · 2021: 28 · 2020: 38 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 32 · 2014: 29 · 2013: 31 · 2012: 19
- FWCI
- 84.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092926, P30DK017047)
- National Center for Research Resources
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes prevention, lifestyle intervention, metformin, cost-effectiveness, Diabetes Prevention Program Outcomes Study, quality-adjusted life years, high-risk adults, direct medical costs, resource utilization (health care), health system perspective, societal perspective
- MeSH terms
- Adult, Combined Modality Therapy, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Prediabetic State, Prognosis, Time Factors, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Reduction Behavior, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.